DexCom, Inc. (DXCM)
NASDAQ
Closed
Aug 24, 2026
Day's Range
91.0452 wk Range
54.11Profile - DXCM - DexCom, Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Medical Devices
Employees
11K
DexCom, Inc. is a leading medical technology company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Its primary products deliver real-time glucose readings through small, wearable sensors that provide accurate, personalized data to users, simplifying daily monitoring and decision-making for people with diabetes. The company's CGM platforms integrate seamlessly with smartphones and insulin delivery devices, enabling features like customizable alerts, trend analysis, and sharing capabilities for caregivers and healthcare providers. DexCom, Inc. focuses on advancing glucose biosensing technology to enhance patient outcomes across all age groups, from children to adults. Its solutions support healthcare professionals in clinical settings and empower individuals with actionable insights for better glycemic control. Founded in 1999 and headquartered in San Diego, California, DexCom, Inc. plays a vital role in the diabetes care sector, driving innovation in remote monitoring and connected health ecosystems within the broader medical device industry.
Profile Details
Type
Common Stock
Address
6340 Sequence Drive
City
San Diego
State
CA
Zip
92121
Country
United States
Phone
858 200 0200
Key Executives - DXCM - DexCom, Inc.
Key executives
Cross Listings - DXCM - DexCom, Inc.
Also listed on
The same company trading on other exchanges.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
